AIM ImmunoTech, Inc. (AIM)

0.5121 -0.01 (-1.52%) USD  |  NYAM  |  Apr 24, 11:46
More

AIM ImmunoTech Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
Curis, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Windtree Therapeutics, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade